School of Medicine and Department of Medicine, University of Washington, Seattle, WA.
School of Medicine and Department of Medicine, University of Washington, Seattle, WA; Veterans Affairs Puget Sound Health Care System, Seattle, WA.
Chest. 2022 Jul;162(1):230-241. doi: 10.1016/j.chest.2022.01.054. Epub 2022 Feb 8.
Annual lung cancer screening (LCS) has mortality benefits for eligible participants; however, studies demonstrate low adherence to follow-up LCS.
What are patients' perspectives on barriers and facilitators to adherence to annual LCS?
Forty participants enrolled in the University of Washington/Seattle Cancer Care Alliance LCS program completed a demographic questionnaire and a semistructured interview based on the Tailored Implementation in Chronic Diseases framework to determine attitudes, barriers, and facilitators to longitudinal LCS. Interviews were coded using principles of framework analysis to identify and compare themes between adherent and nonadherent participants.
The 40 participants underwent initial LCS in 2017 with negative results. Seventeen were adherent to follow-up annual LCS, whereas 23 were not. Seven overall themes emerged from qualitative analysis, which are summarized as follows: (1) screening experiences are positive and participants have positive attitudes toward screening; (2) provider recommendation is a motivator and key facilitator for most patients; (3) many patients are influenced by personal factors and symptoms and do not understand the importance of asymptomatic screening; (4) common barriers to longitudinal screening include cost, insurance coverage, accessibility, and other medical conditions; (5) patients have variable preferences about how they receive their screening results, and many have residual questions about their results and future screening; (6) reminders are an important facilitator of annual screening; and (7) most patients think a navigator would be beneficial to the screening process, with different aspects of navigation thought to be most helpful. Those who were not adherent more commonly reported individual barriers to screening, competing health concerns, and less provider communication.
Key facilitators (eg, patient reminders, provider recommendations) may improve long-term screening behavior, and a number of barriers to the screening process could be addressed through patient navigation.
年度肺癌筛查(LCS)对符合条件的参与者具有降低死亡率的益处;然而,研究表明,参与者对后续 LCS 的依从性较低。
患者对坚持年度 LCS 的障碍和促进因素有哪些看法?
40 名参加华盛顿大学/西雅图癌症护理联盟 LCS 计划的参与者完成了一份人口统计学问卷和基于慢性病个体化实施框架的半结构化访谈,以确定他们对纵向 LCS 的态度、障碍和促进因素。访谈采用框架分析的原则进行编码,以确定和比较依从性和非依从性参与者之间的主题。
这 40 名参与者在 2017 年进行了首次 LCS,结果为阴性。其中 17 名参与者坚持进行后续年度 LCS,而 23 名参与者未坚持。通过定性分析得出了七个总体主题,概括如下:(1)筛查体验是积极的,参与者对筛查持积极态度;(2)医生的推荐是大多数患者的动机和关键促进因素;(3)许多患者受到个人因素和症状的影响,不理解无症状筛查的重要性;(4)纵向筛查的常见障碍包括费用、保险覆盖范围、可及性和其他医疗状况;(5)患者对接收筛查结果的方式有不同的偏好,许多患者对其结果和未来的筛查仍有疑问;(6)提醒是年度筛查的重要促进因素;(7)大多数患者认为导航员对筛查过程有益,导航的不同方面被认为是最有帮助的。那些不依从的人更常报告个人筛查障碍、竞争的健康问题以及较少的医生沟通。
关键的促进因素(例如,患者提醒、医生推荐)可能会改善长期的筛查行为,而筛查过程中的一些障碍可以通过患者导航来解决。